HomeREGULATORY
REGULATORY

PMDA’s Review Division Remains in the Red, with Loss of 2-2.5 Billion Yen Expected for Full Year
(Nov.6.2017)

The review division of the Pharmaceuticals and Medical Devices Agency (PMDA) cannot break out of its deficit ...
(LOG IN FOR FULL STORY)